Skip to main content
ADDvise Group B logo

ADDvise Group B — Investor Relations & Filings

Ticker · ADDV ISIN · SE0001306119 LEI · 549300C17TZXE1IEOA66 ST Wholesale and retail trade
Open in API
Filings indexed 399 across all filing types
Latest filing 2022-10-14 Regulatory Filings
Country SE Sweden
Listing ST ADDV

About ADDvise Group B

https://www.addvisegroup.com/

ADDvise Group is an international life science company that provides comprehensive solutions, including products and services, to the healthcare and research sectors. The group operates through two primary business areas: Lab and Healthcare. The Lab division supplies laboratory equipment, furnishings, and consumables to public and private research facilities. The Healthcare division offers medical devices and equipment to various healthcare providers. ADDvise Group expands through the acquisition and development of high-quality companies, utilizing a decentralized ownership model that allows its subsidiaries to operate with autonomy while benefiting from corporate support.

Recent filings

Filing Released Lang Actions
ADDvise Groups valberedning inför årsstämman 2023
Regulatory Filings Classification · 95% confidence The document is a press release from ADDvise Group announcing the composition of its nomination committee (valberedning) for the upcoming 2023 Annual General Meeting. It details the members of the committee, their roles, and how shareholders can submit nominations. This type of corporate governance announcement regarding board preparation and committee formation falls under general regulatory filings as it does not fit into specific categories like AGM-R (which are materials for the meeting itself) or DVA (voting results).
2022-10-14 Swedish
ADDvise Group’s nomination committee for the Annual General Meeting 2023
Regulatory Filings Classification · 90% confidence The document is a press release announcing the composition of the nomination committee for the upcoming 2023 Annual General Meeting. It details the members of the committee and the process for shareholders to submit proposals. Since this document relates to the preparation and governance structure for an AGM rather than the meeting materials themselves or a specific voting result, it falls under the category of general regulatory announcements or governance-related disclosures. Given the specific nature of the announcement regarding board/committee formation, it is best classified as a Regulatory Filing (RNS) as it does not fit the specific criteria for AGM-R (which are materials for the meeting) or PSI (which are proxy solicitations).
2022-10-14 English
ADDvise tecknar avsiktsförklaring att förvärva CliniChain Holding B.V.
M&A Activity Classification · 100% confidence The document is a press release announcing that ADDvise Group AB has signed a letter of intent to acquire CliniChain Holding B.V. It details the acquisition terms, financial impact, and strategic rationale. This falls squarely under the definition of M&A activity (takeover/acquisition announcement).
2022-09-06 Swedish
ADDvise signs Letter of Intent to acquire CliniChain Holding B.V.
M&A Activity Classification · 100% confidence The document is a press release announcing that ADDvise Group AB has signed a Letter of Intent to acquire CliniChain Holding B.V. It details the purchase price, financing, and strategic rationale for the acquisition. This falls squarely under the definition of M&A activity (takeover bids/acquisitions).
2022-09-06 English
ADDvise erhåller order till ett värde av 640 000 USD
Regulatory Filings Classification · 95% confidence The document is a short press release (1,410 characters) announcing a specific business contract (an order for a stem cell lab in Dubai). It does not contain financial statements, annual reports, or other specific filings listed. As it is a general corporate announcement regarding business operations that does not fit into the other specific categories, it is classified as a Regulatory Filing (RNS).
2022-08-31 Swedish
ADDvise receives order worth USD 640,000
Regulatory Filings Classification · 95% confidence The document is a short press release announcing a specific business order received by a subsidiary of ADDvise Group AB. It does not constitute a financial report, proxy, or governance document, but rather a general corporate announcement regarding business operations. As it does not fit into the specific categories for financial results, dividends, or share transactions, it falls under the general regulatory announcement category.
2022-08-31 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.